Immuneel Therapeutics
Bengaluru · Founded 2018
About Immuneel Therapeutics
Immuneel Therapeutics provides pioneering cell and gene therapies for cancer treatment. They develop CAR-T cell therapies from patients' blood cells by genetically modifying healthy immune cells to target malignant cells, giving cancer patients access to revolutionary cell-based immunotherapies.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $27.1M
- Funding stage: Early Stage Venture
- Last round: Grant (Jun 2025)
- Website: https://immuneel.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/immuneel-therapeutics-103916 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.